Remedium Lifecare Ltd Financials
Company Logo

Remedium Lifecare Ltd Financial Statement

Remedium Lifecare Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2025
Revenue21.85
Operating Expense22.58
Net Profit-0.37
Net Profit Margin-1.69
Earning Per ShareTBA
EBIDTA-0.73
Effective Tax RateTBA

Remedium Lifecare Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual222.50
Operating Expenses Annual224.31
Operating Profit Annual8.99
Interest Annual5.29
Depreciation0.04
Net Profit Annual1.53
Tax Annual2.13

Remedium Lifecare Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning1.52
Cash Flow from Operations-1,078.63
Cash Flow from Investing0.06
Cash Flow from Financing1,078.40
Cash Flow at the End1.36

Remedium Lifecare Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)5.10
PBIT Margin (%)5.08
PBT Margin (%)4.41
Net PROFIT Margin (%)0.69
Return On Networth / Equity (%)3.55
Return On Networth /Employed (%)1.76
Return On Assets (%)0.24
Total Debt / Equity (X)13.90
Asset Turnover Ratio (%)0.35

Remedium Lifecare Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual0.01
Total Current Assets Annual1,539.54
Non Current Assets Annual0.11
Total Shareholders Funds Annual43.30
Total Assets Annual1,539.65

Remedium Lifecare Ltd Earning Calls

EPS (INR)

Expected

0.05

Reported

0.05

Surprise

0.00%

Mar 2025

EPS beaten by 0.00%

FAQS on Remedium Lifecare Ltd Financials

As of Oct 2, 2025, Remedium Lifecare Ltd has a market capitalization of 73.38 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Remedium Lifecare Ltd is not with a debt-to-equity ratio of 26.36.

In FY 2024 , Remedium Lifecare Ltd recorded a total revenue of approximately 222.50 Cr marking a significant milestone in the company's financial performance.

Remedium Lifecare Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.6% and -0.4% annually, respectively..

Remedium Lifecare Ltd's current PE ratio is 47.96.

Remedium Lifecare Ltd's ROCE averaged 41.8% from the FY ending March 2023 to 2025, with a median of 54.0%. It peaked at 70.6% in March 2023, reflecting strong capital efficiency over the period..

Remedium Lifecare Ltd's latest EBIT is Rs. 8.95 Cr, surpassing the average EBIT of Rs. 23.53 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions